MKS Inc. SEC filings document operating results, capital-structure activity and governance matters for a Nasdaq-listed provider of technology solutions for semiconductor manufacturing, electronics and packaging, and specialty industrial applications. Form 8-K reports disclose results of operations and financial condition, financial guidance updates, material definitive agreements, debt refinancing activity, senior notes, credit facilities and registered common stock information.
The company’s proxy materials cover board and shareholder voting matters, executive compensation and related governance disclosures. Other current reports address officer transitions and compensation arrangements, providing formal records of management, governance and financing developments tied to MKS’s public-company structure.
Q2-25 highlights (MKSI 10-Q): Revenue climbed 9.7% YoY to $973 m as product sales grew 10% and service 7%. Net income surged to $62 m ($0.92 EPS) from $23 m, lifting 1H profit to $114 m. Gross margin slipped 60 bps to 46.6% on mix, but operating margin improved 40 bps to 13.9% on disciplined opex. End-market mix: Semiconductor +17%, Electronics & Packaging +16%, Specialty Industrial –5%.
Cash & balance sheet: Operating cash flow jumped 62% to $306 m, funding $47 m capex, $45 m buybacks and $30 m dividends. Cash ended at $674 m (-$40 m YTD). Debt fell $131 m to $4.36 b after two $100 m voluntary prepayments and January repricing; weighted-avg rate 5.9%. Interest expense dropped 30% to $55 m. Equity rose to $2.55 b, OCI loss narrowed to $84 m. Company remains covenant-compliant; no guidance provided.
MKS Inc. (MKSI) – Form 4 insider transaction
Director Jacqueline F. Moloney reported the sale of 300 common shares on 01 Aug 2025 at $92.10 each, realizing ≈$27.6 k in gross proceeds. The sale was carried out under a Rule 10b5-1 trading plan adopted on 10 Sep 2024, indicating it was pre-arranged rather than discretionary.
After the trade, Moloney directly owns 11,862.304 shares. No derivative securities were involved and her insider status remains “Director.”
The disposition equals <0.1 % of her reported stake and is insignificant versus MKSI’s ~67 m shares outstanding, suggesting limited market impact. Nonetheless, investors often monitor any insider selling; the 10b5-1 disclosure mitigates potential negative interpretation.